These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24452067)

  • 1. Vancomycin monitoring in children using bayesian estimation.
    Le J; Ngu B; Bradley JS; Murray W; Nguyen A; Nguyen L; Romanowski GL; Vo T; Capparelli EV
    Ther Drug Monit; 2014 Aug; 36(4):510-8. PubMed ID: 24452067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a pediatric population pharmacokinetic model for vancomycin.
    Hahn A; Frenck RW; Zou Y; Vinks AA
    Ther Drug Monit; 2015 Jun; 37(3):413-6. PubMed ID: 25423413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
    Fewel N
    J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.
    Le J; Capparelli EV; Wahid U; Wu YS; Romanowski GL; Tran TM; Nguyen A; Bradley JS
    Clin Ther; 2015 Jun; 37(6):1340-51. PubMed ID: 26031618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
    Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
    AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
    Beccari MV; Seabury RW; Mogle BT; Kufel WD; Miller CD; Steele JM
    J Am Pharm Assoc (2003); 2020; 60(5):729-733. PubMed ID: 32224054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
    Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
    J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin.
    Lee BV; Fong G; Bolaris M; Neely M; Minejima E; Kang A; Lee G; Gong CL
    Clin Microbiol Infect; 2021 Sep; 27(9):1346.e1-1346.e7. PubMed ID: 33221430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
    Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
    Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.
    Oda K; Hashiguchi Y; Kimura T; Tsuji Y; Shoji K; Takahashi Y; Matsumoto K; Kawamura H; Saito H; Takesue Y
    Pharm Res; 2021 Apr; 38(4):637-646. PubMed ID: 33782837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.